ImmunityBio (NASDAQ:IBRX) reported its Q4 earnings results on Tuesday, March 19, 2024 at 04:31 PM. Here’s what investors need to know about the announcement. EarningsImmunityBio missed estimated earnings by -111.00000000000001%, reporting an EPS of $-0.38 versus an estimate of $-0.18. Revenue was up $66 thousand from the same period last year. Past Earnings PerformanceLast quarter the company beat on EPS by $0.08 which was followed by a 9.0% increase in the share price the next day. ** Listen to the earnings announcement yourself by clicking here. ** To track all earnings releases for Immunity…